Advanced search
Publication Cover
Immunological Medicine Volume 45, 2022 - Issue 1
Submit an article Journal homepage
2,685
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Arthritis-associated osteoclastogenic macrophages (AtoMs) participate in pathological bone erosion in rheumatoid arthritis

Tomoya Agemuraa Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, JapanORCID Iconhttps://orcid.org/0000-0001-6374-5999
ORCID Icon,
Tetsuo Hasegawaa Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, JapanORCID Iconhttps://orcid.org/0000-0001-7737-9491
ORCID Icon,
Shinya Yaria Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, JapanORCID Iconhttps://orcid.org/0000-0001-7915-5926
ORCID Icon,
Junichi Kikutaa Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Japan;b WPI-Immunology Frontier Research Center, Osaka University, Suita, Japan;c Laboratory of Bioimaging and Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, JapanORCID Iconhttps://orcid.org/0000-0002-1549-5961
ORCID Icon &
Masaru Ishiia Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences, Osaka University, Suita, Japan;b WPI-Immunology Frontier Research Center, Osaka University, Suita, Japan;c Laboratory of Bioimaging and Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4215-007X
ORCID Icon
Pages 22-26 | Received 22 Apr 2021, Accepted 14 Jun 2021, Published online: 30 Jun 2021

References

  • Teitelbaum S, Ross F. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4(8):638–649.
  • Rivollier A, Mazzorana M, Tebib J, et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood. 2004;104(13):4029–4037.
  • Nomura K, Kuroda S, Yoshikawa H, et al. Inflammatory osteoclastogenesis can be induced by GM-CSF and activated under TNF immunity. Biochem Biophys Res Commun. 2008;367(4):881–887.
  • Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 2000;191(2):275–286.
  • Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8(11):656–664.
  • McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–2219.
  • Charles JF, Hsu L-Y, Niemi EC, et al. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest. 2012;122(12):4592–4505.
  • Ibáñez L, Abou-Ezzi G, Ciucci T, et al. Inflammatory osteoclasts prime TNFα-producing CD4+ T cells and express CX3 CR1. J Bone Miner Res. 2016;31(10):1899–1808.
  • Werner D, Simon D, Englbrecht M, et al. Early changes of the cortical micro-channel system in the bare area of the joints of patients with rheumatoid arthritis. Arthritis Rheumatol. 2017;69(8):1580–1587.
  • Hasegawa T, Kikuta J, Sudo T, et al. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Nat Immunol. 2019;20(12):1631–1643.
  • Hasegawa T, Kikuta J, Sudo T, et al. Development of an intravital imaging system for the synovial tissue reveals the dynamics of CTLA-4 Ig in vivo. Sci Rep. 2020;10(1):13480.
  • Ishii M, Egen J, Klauschen F, et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature. 2009;458(7237):524–528.
  • Ishii M, Kikuta J, Shimazu Y, et al. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med. 2010;207(13):2793–2798.
  • Kikuta J, Wada Y, Kowada T, et al. Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest. 2013;123(2):866–873.
  • Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71–82.
  • Lam EF, Brosens J, Gomes A, et al. Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer. 2013;13(7):482–495.
  • Hegde N, Sanders D, Rodriguez R, et al. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Nat Chem. 2011;3(9):725–731.
  • Halasi M, Gartel AL. A novel mode of FoxM1 regulation: positive auto-regulatory loop. Cell Cycle. 2009;8(12):1966–1967.
  • Kwok JM-M, Myatt SS, Marson MC, et al. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther. 2008;7(7):2022–2032.
  • Byrne R, Rath E, Hladik A, et al. A dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell migration in the collagen-induced arthritis model. PLoS One. 2012;7(4):e35194.
  • Prendergast CT, Patakas A, Al-Khabouri S, et al. Visualising the interaction of CD4 T cells and DCs in the evolution of inflammatory arthritis. Ann Rheum Dis. 2018;77(4):579–588.
  • Houle MA, Couture CA, Bancelin S, et al. Analysis of forward and backward second harmonic generation images to probe the nanoscale structure of collagen within bone and cartilage. J Biophotonics. 2015;8(11–12):993–901.
  • Chen X, Nadiarynkh O, Plotnikov S, et al. Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure. Nat Protoc. 2012;7(4):654–669.
  • Linsley PS, Wallace PM, Johnson J, et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science. 1992;257(5071):792–795.
  • Knoerzer DB, Karr RW, Schwartz BD, et al. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig. J Clin Invest. 1995;96(2):987–993.
  • Tanaka Y, Takeuchi T, Umehara H, et al. Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. Mod Rheumatol. 2018;28(1):58–65.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.